In the US, some CNS activities were discovered at Children's Hospital of Boston in 1995, and Children's licensed patents covering uses of memantine outside the field of ophthalmology to Neurobiological Technologies (NTI) in 1995.[30] In 1998 NTI amended its agreement with Children's to allow Merz to take over development.[31]